Symbiotic Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.50 Cr
as on 18-07-2024
- Paid Up Capital ₹ 1.28 Cr
as on 18-07-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.91 Cr
as on 18-07-2024
- Satisfied Charges ₹ 8.64 Cr
as on 18-07-2024
- Revenue -4.89%
(FY 2022)
- Profit -36.93%
(FY 2022)
- Ebitda -15.85%
(FY 2022)
- Net Worth 12.98%
(FY 2022)
- Total Assets 37.04%
(FY 2022)
About Symbiotic Sciences
The Corporate was formerly known as Symbiotic Science Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 Cr and a paid-up capital of Rs 1.28 Cr.
The company currently has active open charges totaling ₹20.91 Cr. The company has closed loans amounting to ₹8.64 Cr, as per Ministry of Corporate Affairs (MCA) records.
Asha Malhotra, Vivek Malhotra, Aditya Malhotra, and One other member serve as directors at the Company.
- CIN/LLPIN
U73100DL2007PTC159662
- Company No.
159662
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Symbiotic Sciences Private Limited offer?
Symbiotic Sciences Private Limited offers a wide range of products and services, including Industrial Fabrics and Textiles, Industrial Fabric.
Who are the key members and board of directors at Symbiotic Sciences?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Asha Malhotra | Director | 23-Feb-2007 | Current |
Vivek Malhotra | Director | 27-Jul-2015 | Current |
Aditya Malhotra | Director | 01-Nov-2008 | Current |
Rakesh Malhotra | Director | 24-Feb-2010 | Current |
Financial Performance and Corporate Structure Insights of Symbiotic Sciences.
Symbiotic Sciences Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 4.89% decrease. The company also saw a substantial fall in profitability, with a 36.93% decrease in profit. The company's net worth Soared by an impressive increase of 12.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Symbiotic Sciences?
In 2022, Symbiotic Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Sidbi Creation Date: 03 Jan 2024 | ₹8.00 Cr | Open |
Hdfc Bank Limited Creation Date: 15 Nov 2023 | ₹5.93 M | Open |
Sidbi Creation Date: 21 Mar 2023 | ₹2.69 Cr | Open |
How Many Employees Work at Symbiotic Sciences?
Symbiotic Sciences has a workforce of 10 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Symbiotic Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symbiotic Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.